ANI Pharmaceuticals, Inc. stock price

ANI Pharmaceuticals, Inc. latest news:


  • 09/07/2017 07:31:22

    Eli Lilly to cut 3,500 jobs after part of cost cutting plan

    Eli Lilly & Co. said it will cut about 3,500 jobs, or about 8.3% of its global workforce, as part of a streamlining plan aimed at cutting costs by $500 million a year. The drug giant expects most of the job cuts to come in the U.S. from a voluntary early retirement program, which it expects to be mostly completed by the end of the year. Other workforce reductions are expected to come from streamlining moves, including site closures. Lilly expects to record charges of $1.2 billion, or 80 cents a share, in the third and fourth quarters of 2017. The company plans to use the cost savings to improve its cost structure and reinvest in its business. "The actions we are announcing today will result in a leaner, more nimble global organization and will accelerate progress towards our long-term goals of growing revenue, expanding operating margins and sustaining the flow of life-changing medicines from our pipeline," said Chief Executive David Ricks. The stock, which slipped less than 0.1%, has gained 9.5% year to date through Wednesday, while the SPDR S&P Pharmaceuticals ETF has rallied 8.9% and the S&P 500 has tacked on 10%.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 08/03/2017 11:36:03

    U.S. Senate reauthorizes FDA to collect fees from drugmakers

    - The U.S. Senate on Thursday passed a bill allowing the Food and Drug Administration to continue collecting fees from drug companies to review new product applications. The FDA Reauthorization Act renews an existing law that expires on Sept. 30 and which provides the majority of FDA funds used to review pharmaceuticals and determine whether they are safe and effective.

  • 08/01/2017 10:27:34

    CORRECTED-BRIEF-Kalobios to change company name to Humanigen (July 27)

    (Corrects spelling of "Humanigen" in third bullet point) KaloBios Pharmaceuticals Inc:

  • 07/27/2017 18:11:21

    BRIEF-Stockholders of Jaguar Animal Health and Napo Pharmaceuticals vote to approve merger

    * Stockholders of Jaguar Animal Health and Napo Pharmaceuticals vote to approve merger Source text for Eikon: Further company coverage:

  • 07/05/2017 12:18:29

    UPDATE 3-Short seller Cohodes hits Canada again with latest target -Exchange Income

    NEW YORK/TORONTO, July 5 (Reuters) - Short seller Marc Cohodes, who has bet against the shares of six Canadian-based companies including Valeant Pharmaceuticals International Inc and Home Capital Group Inc, said on Wednesday that he is targeting yet another Canadian firm - Exchange Income Corp.

  • 07/05/2017 09:11:50

    Short seller Cohodes targets Canadian firm Exchange Income Corp

    NEW YORK/TORONTO (Reuters) - Short seller Marc Cohodes, who has famously bet against the shares of six Canadian-based companies including Valeant Pharmaceuticals International Inc and Home Capital...

  • 06/27/2017 15:51:02

    BRIEF-Cyclacel Pharmaceuticals says approved extension of employment agreements with CEO and CFO

    Cyclacel Pharmaceuticals Inc(CYCC). * Cyclacel pharmaceuticals - compensation and organization development committee approved extension of employment agreements with ceo spiro rombotis, cfo paul mcbarron. * Cyclacel Pharmaceuticals Inc(CYCC) - extension agreements to be effective as of july 1, 2017 - sec filing Source text for Eikon: Further company coverage:

  • More trends:

    Anika Therapeutics Inc.ANIK | ANSYS, Inc.ANSS | Antares Pharma, Inc.ATRS | Anthera Pharmaceuticals, Inc.ANTH | Aoxin Tianli Group, Inc.ABAC | API Technologies Corp.ATNY | Apigee CorporationAPIC | Apogee Enterprises, Inc.APOG | Apollo Education Group, Inc.APOL | Apollo Investment CorporationAINV |